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Amyloid β (Aβ) peptide, a causative agent of Alzheimer’s disease, forms two types of 
aggregates: oligomers and fibrils. These aggregates induce inflammatory responses, such as 
interleukin-1β (IL-1β) production by microglia, which are macrophage-like cells located in the 
brain. In this study, we examined the effect of the two forms of Aβ aggregates on IL-1β 
production in mouse primary microglia. We prepared Aβ oligomer and fibril from Aβ (1–42) 
peptide in vitro. We analyzed the characteristics of these oligomers and fibrils by electrophoresis 
and atomic force microscopy. Interestingly, Aβ oligomers but not Aβ monomers or fibrils 
induced robust IL-1β production in the presence of lipopolysaccharide. Moreover, Aβ oligomers 
induced endo/phagolysosome rupture, which released cathepsin B into the cytoplasm. Aβ 
oligomer-induced IL-1β production was inhibited not only by the cathepsin B inhibitor CA-074-
Me but also by the reactive oxygen species (ROS) inhibitor N-acetylcysteine. Random chemical 
crosslinking abolished the ability of the oligomers to induce IL-1β. Thus, multimerization and 
fibrillization causes Aβ oligomers to lose the ability to induce IL-1β. These results indicate that 
Aβ oligomers, but not fibrils, induce IL-1β production in primary microglia in a cathepsin B- 
and ROS-dependent manner. 
 







Amyloid β (Αβ) peptides form aggregates that accumulate in senile plaques within the brain 
tissue of patients with Alzheimer’s disease (AD). This phenomenon is the pathologic hallmark of 
AD [1]. Αβ forms 2 distinct types of aggregates, soluble Αβ oligomers and insoluble Αβ fibrils 
(see ref. [2]). Both types of Aβ aggregates seem to induce production of the inflammatory 
cytokine IL-1β via NOD-like receptor family, pyrin domain containing 3 (NLRP3) an 
inflammasome protein. IL-1β is one of the most prominently expressed cytokines in brain tissue 
of AD patients, and it is thought to cause neurodegeneration [3]. 
Induction of IL-1β requires 2 sequential signals [4]. The first signal is transduced through 
toll-like receptors (e.g., TLR4) and leads to the production of the pro-form of IL-1β. The second 
signal occurs via inflammasome activation, which requires lysosomal cathepsin B [5,6] and 
reactive oxygen species (ROS) [7,8]. Aβ aggregates as well as small particles such as asbestos 
lead to cathepsin B leakage from phagolysosomes, which binds directly to NLRP3 and activates 
it [9]. In addition, the Aβ aggregates/particles also induce mitochondrial damage and subsequent 
ROS production [8], leading to activation of the NLRP3 inflammasome [10]. After activation, 
the NLRP3 inflammasome facilitates activation of caspase-1, and then pro-IL-1β is processed to 
its bioactive form [11]. 
Microglia reside in the brain [12] and monitor the functional status of neuronal cells, tissue 
metabolism, inflammation, and cell death [13]. The inflammatory and immunological processes 
mediated by microglia are thought to play a pivotal role in the initiation and progression of AD 






Although it has been shown that Aβ aggregates induce IL-1β [5], which types of aggregates 
induce IL-1β production by primary microglia remains controversial. In this study, we examined 
which types of aggregates induce IL-1β production by primary microglia by generating 
size/shape-defined Aβ preparations with low cross-contamination between oligomer and fibril 
forms. 
 
2. Materials and methods 
2.1. Mice 
BALB/c mice were purchased from Japan SLC (Hamamatsu, Japan) and were housed and 
bred under specific pathogen-free conditions. All animal experiments were performed in 
accordance with the Kyoto University Institutional Guidelines for Animal Use and 
Experimentation. 
 
2.2. Antibodies and reagents 
Purified anti-mouse IL-1β monoclonal antibody (B122) and biotinylated anti-rat IgG2bκ 
were purchased from BD Biosciences (San Jose, CA). Biotinylated anti-IL-1β and FITC-labeled 
anti-rabbit antibodies were purchased from eBioscience (San Diego, CA) and Jackson 
ImmunoResearch (West Grove, PA), respectively. Rabbit anti-Aβ antibody and Alexa-647-
conjugated anti-Lamp1 monoclonal antibody (1D4B) were purchased from Cell Signaling 
Technology (Danvers, MA) and BioLegend (San Diego, CA), respectively. RPMI1640 and 
DMEM were purchased from Invitrogen (Carlsbad, CA), and ultra-pure LPS (E. coli 0111:B4) 





purchased from Sigma-Aldrich (St. Louis, MO), and the cathepsin B inhibitor CA-074-Me was 
purchased from Calbiochem (Darmstadt, Germany). 
 
2.3. Preparations of Aβ oligomers and fibrils 
Aβ oligomers and fibrils were prepared from Aβ(1–42) peptides (Peptide Institute, Osaka, 
Japan) as previously described [15] with some modifications (see Fig. S1). To prepare Aβ 
oligomers, peptide dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) was diluted in 
phenol red-free RPMI1640 and incubated for 24 h at 4°C. To prepare Aβ fibrils, the peptide 
solution was diluted with 100 mM HCl (instead of 10 mM HCl) and then incubated for 24 h at 
37°C. The fibril preparation was then centrifuged, and the resulting pellet was washed and 
resuspended in phenol red-free RPMI1640. The washing step was repeated 3 times to remove Aβ 
oligomers. To prepare Aβ monomers, the peptide solution was diluted with phenol red-free 
RPMI1640, ultrasonicated for 10 min, and then passed through a 0.22-µm membrane filter 
(Millipore, Billerica, MA). 
 
2.4. AFM imaging and analysis 
The AFM analysis was performed as described previously [16]. The Aβ samples were 
prepared by diluting the preformed Aβ solution with PBS to 10 nM. Aliquots of the diluted 
samples (20 µL) were spotted on freshly cleaved mica and incubated at room temperature (RT) 
for 10 min. In some cases, the mica surface was first treated with 10 mM spermidine (Nacalai 
Tesque, Kyoto, Japan) for 10 min prior to spotting of the sample. 
Atomic force microscopy (AFM) images were obtained with a Multimode AFM equipped 





CA). The microscope was operated in Tapping Mode™ at a scanning rate of 1.0–2.0 Hz with 512 
× 512 pixels. Rectangular silicon cantilevers with sharpened tetrahedral tips were used (OMCL 
AC160TS; Olympus, Japan). The probes had a tip radius of approximately 7 nm, a resonant 
frequency of about 300 kHz, and a spring constant of about 26 N/m. Images shown were 
flattened with Nanoscope (v.5.31 r1) software and exported as tiffs. The flattened SPM images 
were opened in Gwyddion (Department of Metrology, Czech Metrology Institute, Czech 
Republic) and analyzed. Aβ molecules or fibrils were marked by selecting all molecules or fibrils 
above a 0.10–0.20-nm threshold. The distributions of various grain characteristics were then 
exported as a raw data file, and then the “measure individual grain” tool was used to select each 
molecule and record the zero basis volume (Vc) and maximum height of each molecule or fibril. 
The values were entered into Origin Lab software (OriginLab Corp., USA), plotted as histograms, 
and fitted with Gaussian curves to obtain the center value for each histogram. The errors are 
reported as the standard deviation of the Gaussian distribution. The contour length of the Aβ 
fibrils was measured with Nanoscope software. These analyses were performed in at least 3 
random fields.  
 
2.5. Silver staining 
Aβ preparations were separated by SDS-PAGE in 4–20% Mini-PROTEAN TGX Precast 
Gels (Bio-Rad, Hercules, CA) and visualized using the Silver Staining Kit, Protein (GE 
Healthcare, Pittsburgh, PA). 
 





The protein content of the Aβ preparations was quantified by Lowry’s method [17] prior to 
each experiment. In some cases, the proportion of each Aβ form was estimated using ImageJ 
software (NIH, Bethesda, MD) by scanning the SDS-PAGE gel after silver staining. The number 
of large fibrils present in each preparation was calculated by subtracting the number of pixels 
representing monomers and oligomers from the total number of pixels in the preparation. 
 
2.7. Preparation of primary microglia and cytokine production assay 
Primary microglia were isolated as described previously [18]. Brain tissues from 5-day 
postnatal mouse pups were used. After digestion, the cell pellet was resuspended in 
DMEM:Ham’s F-12 (1:1) supplemented with 10% FCS, 100 U/mL penicillin, and 100 µg/mL 
streptomycin (DF-10). Cells were seeded into flasks at 1.0–2.0 × 107 cells/75 cm2. The medium 
was changed every 2 to 3 days. Ten days later, the flasks were shaken gently for 2 min, and then 
the floating cells were collected. As determined by flow cytometry, over 90% of the floating cells 
were CD11b+ CD45low microglia. 
Microglia were plated at a density of 2.5 × 104 cells/100 µL/well into 96-well tissue culture 
plates and stimulated with the Aβ preparations in the presence of 100 ng/mL LPS for 24 h. In 
some experiments, cells were incubated with 5 µM CA-074-Me and 2.5 mM NAC for 1 h before 
stimulation. Then, IL-1β production was determined by ELISA, and the production of other 
cytokines was assessed using a cytometric bead array (BD Biosciences). 
 
2.8. Immunostaining and microscopic analysis 
After 2 h of incubation on poly-L-lysine-coated cover slips, adherent microglia (3.0 × 104) 





for 20 min and incubated with 0.1% saponin for 20 min. Specimens were then treated with an 
anti-CD32/64 antibody and incubated with an anti-Aβ antibody and a FITC-anti-rabbit antibody. 
Next, they were incubated with an Alexa-647-conjugated anti-Lamp-1 antibody and stained with 
4'-diamidino-2-phenylindole (Molecular Probes, Eugene, OR) for 20 min. Specimens were 
observed using a deconvolution microscope (BX51-FL; Olympus) and SlideBook imaging 
software (Intelligent Imaging Innovation, Denver, CO). 
 
2.9. Detection of cathepsin B leakage from endo/phagolysosomes 
Cellular localization of active cathepsin B was monitored using a fluorescent cathepsin B 
substrate (Magic Red; Immunochemistry Technologies, Bloomington, MN). After incubation for 
2 h in glass-bottom dishes (at a density of 4.0 × 104 cells/well), microglia were stimulated for 24 
h as described above. Magic Red was added to the culture and incubated for the last 20 min 
according to the manufacturer’s protocols. The cells were then observed using a BZ-8000 
BioZero live-cell imaging device (Keyence, Osaka, Japan). 
 
2.10. Aβ oligomer crosslinking 
Aβ oligomer prepared in PBS was crosslinked using 2 mM ethylene glycol 
bis(sulfosuccinimidylsuccinate) (sulfo-EGS, Thermo Scientific Pierce, Rockford, IL) at room 
temperature for 45 min and then quenched with 20 mM Tris-HCl (pH 7.2). The preparations 
were dialyzed against PBS before use. 
 





Data are expressed as the mean (SD) of triplicate cultures. Statistical significance was 
determined using a two-tailed Student’s t-test. All experiments were performed at least twice, 
and representative results are shown. 
 
3. Results 
3.1. Preparation and characterization of Aβ 
Monomer, oligomer, and fibril Aβ preparations were obtained as shown in Fig. S1. All 3 
preparations were analyzed by SDS-PAGE and silver staining (Fig. 1A, B). The oligomer 
preparation contained 2 types of Aβ aggregates as well as monomers, whereas the fibril 
preparation contained large fibrillar aggregates that could not penetrate the polyacrylamide gel. 
The fibril preparation also contained monomers and a very small amount of oligomers (Fig. 1B). 
The gel scanning results (Fig. 1C, D) showed that the monomer preparation contained less than 
20% oligomer contaminants and the oligomer preparation consisted of approximately 40% 
oligomers and 60% monomers (Fig. 1E). The fibril preparation contained approximately 2/3 
fibrils and 1/3 monomers, with a very small amount of oligomers. 
The sizes and shapes of the Aβ preparations were further analyzed using AFM. The 
oligomer preparation contained globular structures with an average z-height of 0.4 ± 0.2 nm but 
no fibril structures (Fig. 1F, left panels). SDS-PAGE and AFM showed that the Aβ 
trimers/tetramers formed large complexes, such as Aβ-derived diffusible ligands (ADDLs) [19]. 
In contrast, the fibril preparation contained long fiber structures (Fig. 1F, right panels). There are 
2 types of Aβ fibrils, type I and type II [20]. The mean z-height of the predominant fibril form 
was 4.1 ± 0.5 nm, and most fibrils were 246–719 nm in length. Therefore, this fibril preparation 






3.2. Uptake of Aβ aggregates and subsequent IL-1β production by primary microglia 
Next, we monitored Aβ uptake from the 3 different Aβ preparations by primary microglia. 
Immunofluorescence staining with an anti-Aβ antibody showed that, Aβ aggregates from both 
the oligomer and fibril preparations were internalized by microglia, and they produced punctuate 
and diffuse signals, respectively (Fig. 2A). In contrast, little signal was observed when the 
monomer Aβ preparation was used. 
We next examined the effect of the Aβ preparations on IL-1β production in primary 
microglia. We found that the oligomer preparation, but not the monomer or fibril preparation, 
induced robust IL-1β production in the presence of LPS when the preparations were used at a 
concentration of 10 µM (Fig. 2B). TNF-α and MCP-1 production in response to LPS were not 
reduced by addition of the Aβ preparations (Fig. S2). Thus, the possibility that the Aβ 
preparations caused heavy cellular damage could be excluded. The oligomer preparation also 
evoked much greater IL-1β production in bone marrow-derived macrophages (BMDMs) than the 
fibril preparation (Fig. S3). These results indicate that Aβ oligomers induce IL-1β production 
more efficiently than Aβ fibrils. 
 
3.3. Cathepsin B and ROS are required for IL-1β production by microglia 
We previously showed that IL-1β production by BMDMs in response to nano-sized latex 
beads (LxB) in the presence of LPS was dependent on cathepsin B and that microglia also 
produced IL-1β in response to nano-sized LxB [21]. Therefore, Aβ-induced IL-1β production 
may occur via a similar mechanism. To address this question, we first checked whether microglia 





cytoplasm was only detected when microglia were cultured with 20 nm LxB, but not with 1,000 
nm LxB (Fig. S4B). Furthermore, addition of the cathepsin B inhibitor CA-074-Me (5 µM) 
suppressed 20 nm LxB-induced IL-1β production, although the inhibitor did not affect TNF-α 
induction (Fig. S4B). In contrast, the ROS inhibitor NAC (2.5 mM) did not affect IL-1β 
production in response to 1,000 nm or 20 nm LxB (data not shown). These results suggest that 
microglia produce IL-1β in response to 20 nm LxB in a cathepsin B-dependent manner, as was 
observed in BMDMs. 
We next checked whether Aβ oligomer-induced IL-1β production is dependent on cathepsin 
B. As shown in Fig. 3A, release of activated cathepsin B into the cytoplasm was observed only 
when microglia were stimulated with the oligomer preparation. When the cells were stimulated 
with the fibril preparation, active cathepsin B was mainly observed as punctate structures, which 
could be endo/phagolysosomes, but it was not observed in the cytoplasm. Moreover, the 
cathepsin B inhibitor significantly reduced oligomer-induced IL-1β production (Fig. 3B, left 
panel), but did not affect TNF-α production (Fig. 3B, right panel). These results indicate that, 
similar to 20 nm LxB, Aβ oligomers induce IL-1β production by microglia in a cathepsin B-
dependent manner. The ROS inhibitor NAC (2.5 mM) unexpectedly suppressed IL-1β 
production (Fig. 3C), which is not consistent with the results obtained with BMDMs and LxB. In 
BMDMs, IL-1β production in response to 20 nm LxB was dependent on cathepsin B but 
independent of ROS [21]. 
 
3.4. Induction of IL-1β by crosslinked Aβ oligomer 
It is likely that the difference in shape between the Aβ oligomer and fibril leads affects the 





is not clear. To investigate this, an oligomer preparation was further crosslinked with sulfo-EGS. 
Crosslinking of the Aβ oligomers generated high molecular weight (>225 kDa) aggregates (Fig. 
4A). The aggregates were globular rather than fibrillar in structure with an average diameter of 
5.3 ± 0.9 nm (Fig. 4B). Analysis of the volume distribution of the cross-linked oligomers by 
AFM showed 2 average sizes, 1,373 ± 1,418 nm3 and 3,498 ± 2,250 nm3 (Fig. S5), 
corresponding to ~180 and ~460 Aβ peptides, respectively. We then examined the ability of the 
crosslinked preparations to induce IL-1β (Fig. 4C), the crosslinked preparation significantly 
reduced IL-1β induction compared to that induced by the oligomer preparation. This result 
suggests that increasing the size of the Aβ aggregates, either by generating fibrils or by 
crosslinking oligomers, abolishes the ability of the aggregates to induce IL-1β production. 
 
4. Discussion 
In this study, we showed that microglia produce IL-1β in response to Aβ oligomer in a 
cathepsin B- and ROS-dependent manner. These results along with the involvement of IL-1β in 
AD [3] are consistent with the observation that treatment with cathepsin [22] and ROS [23] 
inhibitors improves AD symptoms. 
Both 20 nm LxB and Aβ oligomer induced leakage of cathepsin B, suggesting that small 
sized particles/aggregates cause rupture of endo/phagolysosomes and subsequent IL-1β 
production. These results are consistent with those obtained with BMDMs and LxB [21]. 
However, Aβ oligomer-induced IL-1β production by microglia is also ROS inhibitor-sensitive. In 
BMDMs, IL-1β is produced in response to 20 nm LxB independent of ROS [21]. Exposure to 20 





downregulation of ROS production [21]. Therefore, unlike LxB, Aβ oligomers may not induce 
strong mitochondria damage. Consequently, ROS-producing mitochondria remain in the cells. 
A large surface area is thought to be important for the bioactivity/toxicity of small particles 
[24]. Since Aβ fibrils have much less surface area than oligomers do, it is thought large Aβ 
aggregates, such as fibrils, do not promote AD and may even be protective against progression of 
AD [2]. This idea was supported by studies on other protein-aggregating disorders such as 
Huntington’s disease [25]. Our data are consistent with this hypothesis because only Aβ 
oligomers but not fibrils or crosslinked oligomers induced IL-1β production. It is likely that 
crosslinking of Aβ oligomers decreases their surface area due to the formation of large molecular 
aggregates, resulting in the loss of IL-1β induction ability.  
Recent studies have shown that, in addition to ADDLs, there are several soluble Aβ 
preparations, such as Aβ*56 and AβO as well as the protofibril Aβ42CC [26]. These Aβ fibrillar 
intermediates are composed of different numbers of Aβ peptides and have diverse sizes, shapes, 
and biological effects. In regards to possible species and structural specificity, it should be noted 
that Parajuli et al. reported ROS-dependent but cathepsin B-independent IL-1β production in 
mouse primary microglia upon stimulation with Aβ oligomers [27]. At present, the reason for 
this discrepancy is not clear, because no precise information about the size/shape of their 
oligomer preparations was provided. One possible explanation is that the oligomers used in those 
studies had different compositions or structures than the ones that we used. 
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Fig. 1. Preparation and characterization of monomer, oligomer, and fibril forms of Aβ. 
(A, B) Silver staining of Aβ preparations after electrophoresis. M, monomers; O, oligomers; F, 
fibrils. (C and D) Histograms of pixel sizes in the areas depicted in (A and B), respectively. The 
areas were scanned from the upper side (top) to the lower side (bottom) of the gel. (E) The 
percentages of monomers, oligomers, and fibrils in the Aβ preparations. (F) AFM analyses of 
oligomer (right panels) and fibril (left panels) preparations. Data represent 1 × 1 µm for the 
oligomer preparation and 2 × 2 µm for the fibril preparation, and 10 nm total z-range. Bar graphs 
show the frequency of each height and length. 
 
Fig. 2. Morphological observations and IL-1β production by microglia stimulated with Aβ 
monomer, oligomer, and fibril preparations. 
(A) Microglia on glass coverslips were stimulated with the Aβ preparations in the presence of 
LPS (100 ng/mL) for 2 h and then stained with anti-Aβ (green), anti-Lamp1 (red), and 4'-
diamidino-2-phenylindole (DAPI; blue). BF, bright field. (B) Microglia were stimulated with 
each Aβ preparation in the presence of LPS for 24 h. IL-1β production was analyzed by ELISA. 
Bar graphs show the mean (SD) of triplicate cultures. None of the Aβ preparations induced IL-1β 
production in the absence of LPS. 
 
Fig. 3. Leakage of cathepsin B into the cytoplasm and the effects of cathepsin B and ROS 





(A) Microglia cultured on cover slips were stimulated with the Aβ preparations in the presence 
of LPS for 24 h and then incubated with a fluorescent cathepsin B substrate for the last 20 min of 
culture. (B) After treatment with the cathepsin B inhibitor CA-074-Me for 1 h, microglia were 
stimulated as described in (A). IL-1β and TNF-α production were analyzed by ELISA and 
cytometric bead array, respectively. (C) After treatment with NAC for 1 h, IL-1β production was 
analyzed as described in (B). Bar graphs show the mean (SD) of triplicate cultures; nd, not 
detected; ns, non-sense; *p < 0.01 (t-test). 
 
Fig. 4. Effect of random crosslinking of oligomer preparations on IL-1β production by microglia. 
(A) The Aβ oligomer preparation was randomly crosslinked with sulfo-EGS and analyzed by 
silver staining. (B) The crosslinked preparations were analyzed by atomic force microscopy. 
Data represent 1 × 1 µm, and a 10-nm total z-range. The bar graph shows the frequency of each 
height. The surface of the mica was treated with spermidine before the preparations were added. 
(C) Microglia were stimulated with the Aβ preparations in the presence of LPS for 24 h. IL-1β 









Stimulation of microglia with latex beads. Microglia were cultured at a density of 2.5 
× 104 cells/100 µL in 1.5-mL microtubes and stimulated with latex beads (Invitrogen, 
Carlsbad, CA) at 0.06% (for 1,000-nm diameter beads) or 0.01% (for 20-nm diameter 
beads) for 9 h in the presence of 10 ng/mL LPS in a stirred culture, as described 
previously [1]. 
 
Preparation of bone marrow-derived macrophages. Bone marrow-derived 
macrophages (BMDMs) were generated by incubating bone marrow cells for 5–6 days 
in RPMI1640 containing 10% fetal calf serum, 50 µM 2-mercaptoethanol, and 15% 
L929 cell culture supernatant. The cells were stored at -80°C. Before use, BMDMs were 
cultured for 2 days. 
 
Estimation of molecular weight from AFM data. The molecular weight of proteins was 
calculated using the following equation: M0 = VcN0/(V1 + dV2), where Vc is the 
molecular volume, N0 is Avogadro’s number, and V1 and V2 are the partial specific 
volumes of the individual protein (0.74 cm3·g–1 and 1 cm3·g–1 water, respectively). The 





Supplementary Fig. 1. Schematic diagram of amyloid β aggregate preparations. 
Lyophilized amyloid β (Aβ) peptide was dissolved in DMSO and diluted in RPMI to 
prepare oligomers and in 100 mM HCl to prepare fibrils, and then incubated for 24 h at 
24°C and 37°C, respectively. The fibril preparation was centrifuged, and the pellet was 
suspended in RPMI. For the monomer preparation, Aβ peptide in DMSO was diluted 










Supplementary Fig. 2. Cytokine production in microglia induced by stimulation 
with amyloid β preparations in the presence of lipopolysaccharide. 
Production of TNF-α and MCP-1 was analyzed by a cytometric bead array as 









Supplementary Fig. 3. Interleukin-1β production by bone marrow-derived 
macrophages in response to amyloid β preparations and lipopolysaccharide. 
Bone marrow-derived macrophages were stimulated with an amyloid β oligomer or 
 S3 
fibril preparation in the presence of lipopolysaccharide. After 24 h, interleukin-1β 

















Supplementary Fig. 4. Cathepsin B-dependent interleukin-1β production by 
microglia in response to 20 or 1,000 nm latex beads. 
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(A) Microglia on coverslips were cultured with 20 or 1,000 nm latex beads in the 
presence of lipopolysaccharide (LPS) for 24 h and then incubated with a fluorescent 
cathepsin B substrate for the last 20 min of culture. (B) After treatment with the 
cathepsin B inhibitor CA-074-Me for 1 h, microglia were stimulated with 20 or 1,000 
nm latex beads in the presence of LPS for 9 h in a stirred culture. Production of IL-1β 
and TNF-α was analyzed by ELISA and cytometric bead array, respectively. The bar 










Supplementary Fig. 5. Volume distribution of cross-linked oligomers in AFM 
analyses 
Volume distribution of cross-linked Aβ oligomers from Figure 4 that were larger than 
428 nm3 (~225 kDa) 
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